BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mausner-Fainberg K, Karni A, George J, Entin-Meer M, Afek A. Eotaxin-2 blockade ameliorates experimental autoimmune encephalomyelitis. World J Immunol 2013; 3(1): 7-14 [DOI: 10.5411/wji.v3.i1.7]
URL: https://www.wjgnet.com/2219-2824/full/v3/i1/7.htm
Number Citing Articles
1
Adi Mor, Michal Segal Salto, Avi Katav, Neta Barashi, Victoria Edelshtein, Mirko Manetti, Yair Levi, Jacob George, Marco Matucci-Cerinic. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosisAnnals of the Rheumatic Diseases 2019; 78(9): 1260 doi: 10.1136/annrheumdis-2019-215119
2
Sung-Jig Lim. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2021; 1302: 91 doi: 10.1007/978-3-030-62658-7_7
3
Michal Segal-Salto, Neta Barashi, Avi Katav, Vicktoria Edelshtein, Arnon Aharon, Sharon Hashmueli, Jacob George, Yaakov Maor, Massimo Pinzani, Dan Haberman, Andrew Hall, Scott Friedman, Adi Mor. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damageJHEP Reports 2020; 2(1): 100064 doi: 10.1016/j.jhepr.2019.100064